249 related articles for article (PubMed ID: 34990493)
1. The lower airways microbiome and antimicrobial peptides in idiopathic pulmonary fibrosis differ from chronic obstructive pulmonary disease.
Knudsen KS; Lehmann S; Nielsen R; Tangedal S; Haaland I; Hiemstra PS; Eagan TM
PLoS One; 2022; 17(1):e0262082. PubMed ID: 34990493
[TBL] [Abstract][Full Text] [Related]
2. The lower airways microbiota and antimicrobial peptides indicate dysbiosis in sarcoidosis.
Knudsen KS; Lehmann S; Nielsen R; Tangedal S; Paytuvi-Gallart A; Sanseverino W; Martinsen EMH; Hiemstra PS; Eagan TM
Microbiome; 2022 Oct; 10(1):175. PubMed ID: 36258251
[TBL] [Abstract][Full Text] [Related]
3. Innate immunity proteins in chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis.
Tsoumakidou M; Bouloukaki I; Thimaki K; Tzanakis N; Siafakas NM
Exp Lung Res; 2010 Aug; 36(6):373-80. PubMed ID: 20653472
[TBL] [Abstract][Full Text] [Related]
4. The role of bacteria in the pathogenesis and progression of idiopathic pulmonary fibrosis.
Molyneaux PL; Cox MJ; Willis-Owen SA; Mallia P; Russell KE; Russell AM; Murphy E; Johnston SL; Schwartz DA; Wells AU; Cookson WO; Maher TM; Moffatt MF
Am J Respir Crit Care Med; 2014 Oct; 190(8):906-13. PubMed ID: 25184687
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of surfactant protein A, surfactant protein D, Clara cell protein 16, S100 protein, trefoil factor 3, and prostatic secretory protein 94 in idiopathic pulmonary fibrosis, sarcoidosis, and chronic pulmonary obstructive disease.
Doubková M; Karpíšek M; Mazoch J; Skřičková J; Doubek M
Sarcoidosis Vasc Diffuse Lung Dis; 2016 Oct; 33(3):224-234. PubMed ID: 27758987
[TBL] [Abstract][Full Text] [Related]
6. Topographic heterogeneity of lung microbiota in end-stage idiopathic pulmonary fibrosis: the Microbiome in Lung Explants-2 (MiLEs-2) study.
Valenzi E; Yang H; Sembrat JC; Yang L; Winters S; Nettles R; Kass DJ; Qin S; Wang X; Myerburg MM; Methé B; Fitch A; Alder JK; Benos PV; McVerry BJ; Rojas M; Morris A; Kitsios GD
Thorax; 2021 Mar; 76(3):239-247. PubMed ID: 33268457
[TBL] [Abstract][Full Text] [Related]
7. The lung microbiome in moderate and severe chronic obstructive pulmonary disease.
Pragman AA; Kim HB; Reilly CS; Wendt C; Isaacson RE
PLoS One; 2012; 7(10):e47305. PubMed ID: 23071781
[TBL] [Abstract][Full Text] [Related]
8. Diversity of Fungi and Bacteria in Bronchoalveolar Lavage Fluid during Development of Chronic Obstructive Pulmonary Disease.
Wu X; Wei X; Li X; Deng J; Zhang J
Jpn J Infect Dis; 2022 Nov; 75(6):560-568. PubMed ID: 35908874
[TBL] [Abstract][Full Text] [Related]
9. Host-Microbial Interactions in Idiopathic Pulmonary Fibrosis.
Molyneaux PL; Willis-Owen SAG; Cox MJ; James P; Cowman S; Loebinger M; Blanchard A; Edwards LM; Stock C; Daccord C; Renzoni EA; Wells AU; Moffatt MF; Cookson WOC; Maher TM
Am J Respir Crit Care Med; 2017 Jun; 195(12):1640-1650. PubMed ID: 28085486
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the airway microbiota of healthy individuals and patients with chronic obstructive pulmonary disease by T-RFLP and clone sequencing.
Zakharkina T; Heinzel E; Koczulla RA; Greulich T; Rentz K; Pauling JK; Baumbach J; Herrmann M; Grünewald C; Dienemann H; von Müller L; Bals R
PLoS One; 2013; 8(7):e68302. PubMed ID: 23874580
[TBL] [Abstract][Full Text] [Related]
11. Changes in the respiratory microbiome during acute exacerbations of idiopathic pulmonary fibrosis.
Molyneaux PL; Cox MJ; Wells AU; Kim HC; Ji W; Cookson WO; Moffatt MF; Kim DS; Maher TM
Respir Res; 2017 Feb; 18(1):29. PubMed ID: 28143484
[TBL] [Abstract][Full Text] [Related]
12. Repeated bronchoscopy in health and obstructive lung disease: is the airway microbiome stable?
Nielsen R; Xue Y; Jonassen I; Haaland I; Kommedal Ø; Wiker HG; Drengenes C; Bakke PS; Eagan TML
BMC Pulm Med; 2021 Nov; 21(1):342. PubMed ID: 34727907
[TBL] [Abstract][Full Text] [Related]
13. The Respiratory Microbiome in Chronic Hypersensitivity Pneumonitis Is Distinct from That of Idiopathic Pulmonary Fibrosis.
Invernizzi R; Wu BG; Barnett J; Ghai P; Kingston S; Hewitt RJ; Feary J; Li Y; Chua F; Wu Z; Wells AU; George PM; Renzoni EA; Nicholson AG; Rice A; Devaraj A; Segal LN; Byrne AJ; Maher TM; Lloyd CM; Molyneaux PL
Am J Respir Crit Care Med; 2021 Feb; 203(3):339-347. PubMed ID: 32692582
[No Abstract] [Full Text] [Related]
14. Severity-related changes of bronchial microbiome in chronic obstructive pulmonary disease.
Garcia-Nuñez M; Millares L; Pomares X; Ferrari R; Pérez-Brocal V; Gallego M; Espasa M; Moya A; Monsó E
J Clin Microbiol; 2014 Dec; 52(12):4217-23. PubMed ID: 25253795
[TBL] [Abstract][Full Text] [Related]
15. Lung Microbiota Contribute to Pulmonary Inflammation and Disease Progression in Pulmonary Fibrosis.
O'Dwyer DN; Ashley SL; Gurczynski SJ; Xia M; Wilke C; Falkowski NR; Norman KC; Arnold KB; Huffnagle GB; Salisbury ML; Han MK; Flaherty KR; White ES; Martinez FJ; Erb-Downward JR; Murray S; Moore BB; Dickson RP
Am J Respir Crit Care Med; 2019 May; 199(9):1127-1138. PubMed ID: 30789747
[No Abstract] [Full Text] [Related]
16. Saliva as a non-invasive specimen for COPD assessment.
Melo-Dias S; Valente C; Andrade L; Marques A; Sousa A
Respir Res; 2022 Jan; 23(1):16. PubMed ID: 35093093
[TBL] [Abstract][Full Text] [Related]
17. Community dynamics and the lower airway microbiota in stable chronic obstructive pulmonary disease, smokers and healthy non-smokers.
Einarsson GG; Comer DM; McIlreavey L; Parkhill J; Ennis M; Tunney MM; Elborn JS
Thorax; 2016 Sep; 71(9):795-803. PubMed ID: 27146202
[TBL] [Abstract][Full Text] [Related]
18. Proteomic studies on receptor for advanced glycation end product variants in idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease.
Ohlmeier S; Mazur W; Salmenkivi K; Myllärniemi M; Bergmann U; Kinnula VL
Proteomics Clin Appl; 2010 Jan; 4(1):97-105. PubMed ID: 21137019
[TBL] [Abstract][Full Text] [Related]
19. Hemoglobin α and β are ubiquitous in the human lung, decline in idiopathic pulmonary fibrosis but not in COPD.
Ishikawa N; Ohlmeier S; Salmenkivi K; Myllärniemi M; Rahman I; Mazur W; Kinnula VL
Respir Res; 2010 Sep; 11(1):123. PubMed ID: 20836851
[TBL] [Abstract][Full Text] [Related]
20. Elevated BALF concentrations of alpha- and beta-defensins in patients with pulmonary alveolar proteinosis.
Mukae H; Ishimoto H; Yanagi S; Ishii H; Nakayama S; Ashitani J; Nakazato M; Kohno S
Respir Med; 2007 Apr; 101(4):715-21. PubMed ID: 17000097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
